Prophecy has maintained its recent growth in SNARE new sales, with YTD growth sitting at 106% as at the end of May comparison. This shows a continuation of the excellent progress in new sales achievement in this financial year as previously reported.
- SNARE sales growth now at 106% YTD to end of May
- Previously reported growth continues
- Bold sales targets surpassed YTD
- Confident that the high growth will persist for the full year
- Sales expectations for the year to be exceeded with healthy pipeline
Management set bold targets for sales growth in the financial year and these have been surpassed through the diligent application of our methodical sales process. Our team has continued its improvement since the half year to now hit a growth of new sales of 106% compared to May last year to date when measured on a fixed exchange rate basis.
With 6 weeks remaining in the financial year, Prophecy is confident of maintaining this sales growth rate through to the end of the full year. The supporting pipeline of prospects is very strong at this stage.
Our SNARE product set continues to exceed expectations for the year and is at the core of our full year expected results. The resources allocated to SNARE this year have paid full dividends, producing a very pleasing growth rate so far, with some room still left for improvement.